Seroprevalence of anti-HAV among patients with chronic viral liver disease
Tuesday, January 25, 2011 - 13:33
in Health & Medicine
A research team from South Korea investigated the current seroprevalence of hepatitis A virus (HAV) antibodies in patients with chronic viral liver disease in Korea. They found that most Korean patients with chronic liver disease and who are above 40 years of age have already been exposed to HAV.